Fosun International Limited · HKEX:656

Fosun International — FY2024 Earnings Presentation

58 slides from Fosun International's earnings presentation, Apr 1, 2025

  1. Slide 1: Strengthen the Core, Shaping for Future

    Strengthen the Core Shaping for Future 2024 Fosun International Annual Results 2025-04-01 | Shanghai

  2. Slide 2: Disclaimer

    Disclaimer This document is not intended to provide a full explanation of any relevant matters of Fosun International Limited (“Fosun” or the “Company”). You must refrain from relying on any information set out in this document. No statement, guarantee or undertaking is or will be made or given at p

  3. Slide 3: Table of Contents

    Table of Contents 01. Financials 02. Business 03. Strategic Development 3

  4. Slide 4: 2024 Financials: Stable Operation of Core Businesses, Robust Overseas Growth

    2024 Financials: Stable Operation of Core Businesses, Robust Overseas Growth 1. Financials 2. Business 3. Strategic Development Total Revenue Overseas Revenue Industrial Operation Profit3 Profit Attributable to Owners of the Parent 192.1 94.78 4.9 (4.35) Billion/RMB Billion/RMB Billion/RMB Billion/R

  5. Slide 5: 2024 Financials: Overall Revenue Steady, Consumer Business Sees Pressure

    2024 Financials: Overall Revenue Steady, Consumer Business Sees Pressure 1. Financials 2. Business 3. Strategic Development Revenue (Billion/RMB) Revenue (Billion/RMB) 17% 26.95 +4.5% 28.16 +0.1% 23.26 23.29 29% 12% Health Wealth 2024H1 2024H2 2024H1 2024H2 62% +0.5% 9% 71% +6.4% 46.31 46.55 51.78 5

  6. Slide 6: 2024 Financials: Core Subsidiaries Consolidating Industrial Foundation

    2024 Financials: 4 Core Subsidiaries Consolidating Industrial Foundation 1. Financials 2. Business 3. Strategic Development 4 Core Subsidiaries Fosun Pharma Yuyuan Billion/RMB Billion/RMB -0.8% YOY -19.3% YOY 41.25 58.15 46.92 40.91 Fosun Pharma 21% 30% Yuyuan 2023 2024 2023 2024 Fosun Tourism 24% G

  7. Slide 7: 2024 Financials: Balance Sheet Remains Robust

    2024 Financials: Balance Sheet Remains Robust 1. Financials 2. Business 3. Strategic Development Public Markets Financing 1 Cash, Bank Balances and Term Average Cost of Borrowings Deposits 13.65 Billion/RMB 106.34 Billion/RMB 5.6% (excl. consolidated subsidiaries) Leverage Ratio Remained Cost of Bor

  8. Slide 8: 2024 Financials: Stable Credit Rating, Successful Issuance of USD Bonds

    2024 Financials: Stable Credit Rating, Successful Issuance of USD Bonds 1. Financials 2. Business 3. Strategic Development The Group’s Credit Metrics Continued to Improve In 2024, S&P Global reiterated Fosun International’s “BB-, Stable Outlook” rating, and fully recognized the benefit of successful

  9. Slide 9: Evolving Finance Strategy to Navigate the Group through Economic Cycle

    Evolving Finance Strategy to Navigate the Group through Economic Cycle 1. Financials 2. Business 3. Strategic Development Strategic Focus, Steady Development 2025: Finance strategy to persist • Further focused on strategic core businesses with market leadership position • For three consecutive years

  10. Slide 10: Global Operating Capabilities Drive Growth and Bolster Resilience

    1 Global Operating Capabilities Drive Growth and Bolster Resilience 1. Financials 2. Business 3. Strategic Development Overseas Business is the Vital Growth Drivers Highlights in Global Operations Fosun Insurance Portugal Fosun Overseas Revenue Eleven-Year CAGR 49% • In 2024, international business

  11. Slide 11: Firm Execution of Non-core Assets Divestments, Strategic Optimization of Asset Portfolio

    2 Firm Execution of Non-core Assets Divestments, Strategic Optimization of Asset Portfolio 1. Financials 2. Business 3. Strategic Development Continuous Optimization of Asset Portfolio through Stable Interest-bearing Liabilities, with a Slight Strategic Investment and Divestment YoY Decline in Net D

  12. Slide 12: Smooth Financing Channels with Diversified Counterparties and Financing Instruments

    3 Smooth Financing Channels with Diversified Counterparties and Financing Instruments 1. Financials 2. Business 3. Strategic Development Steady Bank Financing Broadened Open Market Financing 境 • 虽然境内公开债券市场对于民营企业挑战重重,但 Domestic Banks: Solid Foundation Re-opened the USD Bond Market after 3 Years • The

  13. Slide 13: Deepening Asset-light Operations, Strengthened Core Competitiveness

    4 Deepening Asset-light Operations, Strengthened Core Competitiveness 1. Financials 2. Business 3. Strategic Development Rehabilitation & Nursing Services: Accelerated Expansion FTG: Asset-light Operations in Full Swing under the Asset-light Model • Jianjia Healthcare continues to expand against the

  14. Slide 14: Finance Strategy Paves a Promising Future

    Finance Strategy Paves a Promising Future 1. Financials 2. Business 3. Strategic Development Unswervingly prioritizing the Group's portfolio, focusing resources on cultivating businesses with the potential to become industry leader Continuously advancing the implementation of asset-light strategies,

  15. Slide 15: Table of Contents

    Table of Contents 01. Financials 02. Business 03. Strategic Development 15

  16. Slide 16: Health

    HEALTH

  17. Slide 17: Health Segment Business Highlights

    Health Segment Business Highlights 1. Financials 2. Business 2.1 Health 3. Strategic Development 2024 Total Revenue Fosun Pharma Fosun Pharma R&D Expenditure 46.55 29% Billion/RMB Revenue: 40.91 Billion/RMB 5.55 Billion/ RMB Health v v v ■ Revenue in 2024 increased by 0.5% yoy, mainly ■ Innovative p

  18. Slide 18: Fosun Pharma's Key Innovative Products Grow Steadily

    Fosun Pharma’s Key Innovative Products Grow Steadily 1. Financials 2. Business 2.1 Health 3. Strategic Development Revenue Net Profit Attributable to Shareholders Revenue Billion/RMB Billion/RMB • Innovative product revenue maintained steady growth, Pharma Med Tech including Serplulimab Injection(PD

  19. Slide 19: Business Highlights – Sustainable and Innovative Product Pipelines

    Business Highlights – Sustainable and Innovative Product Pipelines 1. Financials 2. Business 2.1 Health 3. Strategic Development • In 2024, developed through independent R&D, co-development, and licensing, 7 innovative products received approval for 16 indications, 8 products, have entered the pre-m

  20. Slide 20: Business Highlights – Deepening Global Business Presence

    Business Highlights – Deepening Global Business Presence 1. Financials 2. Business 2.1 Health 3. Strategic Development • Under the industry background of VBP and NRDL negotiation, both generic drugs and innovative drugs are facing price challenges • Continuing to implement the international strategy

  21. Slide 21: Medical Devices & Diagnostics Brands

    Medical Devices & Diagnostics Brands 1. Financials 2. Business 2.1 Health 3. Strategic Development Aesthetic Medical Professional Medical Device and Fosun Diagnostics Respiratory Care Intuitive Surgical is a global leader in surgical robotics ✓ To advance product iterations and bring The world’s lea

  22. Slide 22: Evolution of the Medical Service & Healthcare Management Model

    Evolution of the Medical Service & Healthcare Management Model 1. Financials 2. Business 2.1 Health 3. Strategic Development Focus on Premium Medical Care and Professional Services Expansion and Optimization of Eco-models Fosun Health is expanding its footprints in medical group, smart healthcare an

  23. Slide 23: Happiness

  24. Slide 24: Happiness Segment Business Highlights

    Happiness Segment Business Highlights 1. Financials 2. Business 2.2 Happiness 3. Strategic Development 2024 Total Revenue Yuyuan Fosun Tourism Group 23% Revenue: Revenue: Happiness 76.71 Billion/RMB 46.92 Billion/RMB 17 Billion/RMB 77% ◼ Revenue decreased by 13.8% yoy, mainly due ◼ With business str

  25. Slide 25: Yuyuan: Solid Operations

    Yuyuan: Solid Operations 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Revenue by Business Gross Profit Operating Revenue Unit: Billion/RMB Unit: Billion/RMB 58.15 • Operating revenue reached RMB 46.92 0.4 billion, down by 19.3%, with the core 2.1 1.5 50.20 46.92 fashion jewelry b

  26. Slide 26: Continued Expansion in Fashion Jewelry, and Steady Growth in Core Products of Liquor Business

    Continued Expansion in Fashion Jewelry, and Steady Growth in Core Products of Liquor Business 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Continued Jewelry Channel Optimization, Increase in Steady Revenue in Fashion Jewelry Fashion Jewelry Smart Selection Stores Unit: Billion/RM

  27. Slide 27: Yuyuan Tourist Mart Continues to Grow, Yuyuan Garden Lantern Festival Shines

    Business Highlights – Yuyuan Tourist Mart Continues to Grow, Yuyuan Garden Lantern Festival Shines in Two Cities 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Yuyuan Garden Lantern Festival Yuyuan Tourist Mart continuously concluded successfully improves its operations Shanghai Yu

  28. Slide 28: FTG: Core Business Keeps Steady, Tourism Operation Hits a New High

    FTG: Core Business Keeps Steady, Tourism Operation Hits a New High 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Tourism Operation Revenue1 Revenue Unit: Billion/RMB Unit: Billion/RMB FTG delivered resilient and stable performance 19.04 17.15 17.00 17.97 +6% -1% Driven by continue

  29. Slide 29: FTG: Privatization Completed — Strategic Retreat for Future Advancement

    FTG: Privatization Completed — Strategic Retreat for Future Advancement 1. Financials 2. Business 2.2 Happiness 3. Strategic Development On December 10, 2024, FTG announced a proposed privatization by wat of a scheme of arrangement at HKD 7.8 per share, with a plan to delist its shares. This privati

  30. Slide 30: Global Operations: Club Med Achieves Record-High Performance

    Global Operations: Club Med Achieves Record-High Performance with Growth in Both Quantity and Price 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Resort capacity2 expanded steadily, Operation Revenue1 hit a new high with growth across three key regions Average daily bed rate1 cont

  31. Slide 31: Operations in China: Strengthening Core Business and Expanding Asset-Light Management

    Operations in China: Strengthening Core Business and Expanding Asset-Light Management 1. Financials 2. Business 2.2 Happiness 3. Strategic Development ULTRAMED Hainan ULTRAMED Hainan Sets Sail as the World’s First AI-Themed Resort ◼ In October 2024, the ULTRAMED Hainan project officially launched. E

  32. Slide 32: Fashion Business: Creative Empowerment and Upgraded Operations Amid Market Shifts

    Fashion Business: Creative Empowerment and Upgraded Operations Amid Market Shifts 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Revenue1 in 2024 declined in face of downward pressure in luxury market The group actively navigated the downturn Lanvin Group’s total revenue (Million/E

  33. Slide 33: Wolves Turned Profitable, Baihe Jiayuan Reduced Cost and Improved Efficiency

    Wolverhampton Turned Profitable, Baihe Jiayuan Reduced Cost and Improved Efficiency 1. Financials 2. Business 2.2 Happiness 3. Strategic Development Business Highlights: 1) Wolverhampton Wanderers FC saw a net profit Financial Performance: of RMB 42 million in 2024, turning a profit after a loss; 2)

  34. Slide 34: Wealth

    FIDELISADE lh ee ae “49 "Se iaP Sarees we WEALTH

  35. Slide 35: Wealth Segment Business Highlights

    Wealth Segment Business Highlights 1. Financials 2. Business 2.3 Wealth 3. Strategic Development 2024 Total Revenue Fosun Insurance Portugal Peak Re Total Premium Revenue: Total Premium Revenue: 55.11 18% Billion/RMB 6.17 Billion/EUR 1.76 Billion/USD Maintaining the top market ■ Revenue grew by 6.4%

  36. Slide 36: Insurance Business Highlights

    Insurance Business Highlights 1. Financials 2. Business 2.3 Wealth 3. Strategic Development Global Footprints Overseas Insurers: Efficient operations become cornerstone of profits 2024 Premium Scale: 74.5 Billion/RMB Steadily expand the business scale, Prudently manage risk exposure, with continuous

  37. Slide 37: Asset Management (Investment) Business Layout

    Asset Management (Investment) Business Layout 1. Financials 2. Business 2.3 Wealth 3. Strategic Development Global Footprints for Asset Management Platforms Strategy & Direction Major Investments 2024 Overall Goals AUM1 2,253.6 Billion/RMB Return to the core of “Insurance + Industry + Investment” vi

  38. Slide 38: Intelligent Manufacturing

  39. Slide 39: Intelligent Manufacturing Segment Business Highlights

    Intelligent Manufacturing Segment Business Highlights 1. Financials 2. Business 2.4 Intelligent Manufacturing 3. Strategic Development 2024 Total Revenue Hainan Mining 26% 15.59 Billion/RMB Net Profit Attributable to Owners of the Parent 710 Million/RMB Intelligent Manufacturing ◼ Revenue increased

  40. Slide 40: Hainan Mining: Strong Performance Against Headwinds, Accelerating Global Expansion

    Hainan Mining: Strong Performance Against Headwinds, Accelerating Global Expansion 1. Financials 2. Business 2.4 Intelligent Manufacturing 3. Strategic Development Resilient Performance Against Odds Iron Ore Steady, Oil & Gas on the Rise Finished Iron Ore Output (10,000 tons) Oil & Gas (10,000 barre

  41. Slide 41: Wansheng: The World's Leading New Functional Materials Enterprise

    Wansheng: The World’s Leading New Functional Materials Enterprise 1. Financials 2. Business 2.4 Intelligent Manufacturing 3. Strategic Development Enhancing operational capability through supply and sales synergy Expanding global presence through strategic marketing network development Sales (10,000

  42. Slide 42: Table of Contents

    Table of Contents 01. Financials 02. Business 03. Strategic Development 42

  43. Slide 43: 2025: Steadfast Progress Amid Uncertainty

    2025: Steadfast Progress Amid Uncertainty 1. Financials 2. Business 3. Strategic Development 3.1 Macro-environment Geopolitical crises persist, deglobalization gathers pace Rising protectionism and global supply chain restructuring • The “Trump 2.0” era • Trump’s tariffs make a global comeback • Geo

  44. Slide 44: Strategy Review: Navigating Economic Cycles with Long-term Vision and Business Streamlining

    Strategy Review: Navigating Economic Cycles with Long-term Vision and Business Streamlining 1. Financials 2. Business 3. Strategic Development 3.2 Strategic Leadership Fosun: Three Decades of Strategic Industry Evolution Phase I: Phase II: Phase III: Phase IV: Phase V: Founding and Domestic Global D

  45. Slide 45: Focused on Four Core Segments, Driven by Innovation and Globalization

    Focused on Four Core Segments, Driven by Innovation and Globalization 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities R&D and commercialization R&D and Resort Baijiu (liquor) business Global insurance operations of macromolecules commercialization of operations and operation

  46. Slide 46: Seizing the AI-Driven Industrial Transformation, Embracing AI Across the Board

    Seizing the AI-Driven Industrial Transformation, Embracing AI Across the Board 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities Health Happiness Wealth Intelligent Manufacturing AI in Drug Discovery AI in Marketing & Customer AI in Customer Service AI in Manufacturing • Henli

  47. Slide 47: Four Core Capabilities to Drive High-quality Development

    Four Core Capabilities to Drive High-quality Development 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities Profound Global Operations Innovation-driven Expand global vision R&D innovation Seize global market gaps Product innovation Global organization + local operations Conten

  48. Slide 48: Domestic & Overseas: Efficient Management, Deep Global Expansion

    Domestic & Overseas: Efficient Management, Deep Global Expansion 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities Chinese Companies: Global Expansion Empowering Overseas Enterprises for Global R&D and Business Development Global Operations Expertise Henlius Global Empowered b

  49. Slide 49: Innovation: Enhancing Competitiveness, Supporting Global Business Growth

    Innovation: Enhancing Competitiveness, Supporting Global Business Growth 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities R&D Product Content Digital Innovation Innovation Innovation Application Fosun Pharma Sunvision Yuyuan Inc. FTG • Hansizhuang®, the self-developed The "Si

  50. Slide 50: Advancing the Creation of Ecosystem Value

    Advancing the Creation of Ecosystem Value 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities 2024 Key Results 52.4% 12 million consumer members at the Group level, contributing 52.4% of the total sales, making a one C 2M percentage point increase year-on-year from 2023 U s e r

  51. Slide 51: FES: Strengthening Fosun's Industrial Edge

    FES: Strengthening Fosun’s Industrial Edge 1. Financials 2. Business 3. Strategic Development 3.3 Core Capabilities Enhance enterprise operation capability to build core competitiveness Industry Exploration Enhance: Enterprise operation and management 01 capabilities and efficiency Ecosystem | Syner

  52. Slide 52: Organizational Development to Excel Core Capabilities

    Organizational Development to Excel Core Capabilities 1. Financials 2. Business 3. Strategic Development 3.4 Organizational Support Global Organization Upgrade: Improved global operational capabilities, enhanced workforce productivity, management innovation, cost reduction, and sustained organizatio

  53. Slide 53: Partnership Mechanism Drives Organizational Vitality

    Partnership Mechanism Drives Organizational Vitality 1. Financials 2. Business 3. Strategic Development 3.4 Organizational Support Fosun’s Pyramid Partner System Featuring “One Axis and Multiple 1 Dimensions” Global Key Talent Goals Global Partners ---Top-level advantages Partners Global Partners Yo

  54. Slide 54: Committed to Global Services, Advancing Corporate Sustainable Development

    Committed to Global Services, Advancing Corporate Sustainable Development 1. Financials 2. Business 3. Strategic Development 3.5 ESG E S G Carbon Neutrality Rural Doctors Program Corporate Governance A total of 422 volunteers have been sent • Continuous optimization/evolution of ERM Target by 2050 t

  55. Slide 55: Excellent ESG Performance with Recognition Worldwide

    Excellent ESG Performance with Recognition Worldwide 1. Financials 2. Business 3. Strategic Development 3.5 ESG ESG Rating ➢ MSCI ESG rating maintained at AA for four consecutive years Related Associations1 ➢ Selected as a constituent of the MSCI CHINA ESG LEADERS 10-40 Index ➢ Subsidiary company FT

  56. Slide 56: Appendix

    FOSUN 22 Appendix FOSUN

  57. Slide 57: Top Secondary Holdings

    Top 20 Secondary Holdings1 As of December 31, 2024 No. Stock Name Market Value % Held2 Market Value (Billion/RMB) (Billion/USD) 1 Fosun Pharma (A+H)3 36.22% 23.13 3.22 2 Yuyuan3 61.88% 15.49 2.16 3 BCP 20.03% 10.60 1.47 4 Hainan Mining3 46.61% 6.73 0.94 5 Fosun Tourism Group3 78.11% 6.68 0.93 6 Wans

  58. Slide 58: 2024 Fosun International Annual Results

    2024 Fosun International Annual Results https://www.fosun.com https://ir.fosun.com Fosun WeChat Fosun IR WeChat Fosun Weibo Fosun Video Fosun Douyin Official Account Official Account Channel

Fosun International — FY2024 Earnings Presentation on 6ix